Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development

Cellular Oncology

Volumn 35, Issue 6, 2012, Pages 473-479

  Bhagat, Rahul ^a   Chadaga, Shilpa ^a   Premalata, C S ^a   Ramesh, G ^a   Ramesh, C ^a   Pallavi, V R ^a   Krishnamoorthy, Lakshmi ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

APC; Ovarian cancer; Promoter methylation; RASSF1A; Tumor Suppressor Genes

Indexed keywords

APC PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYSTADENOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; MIDDLE AGED; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; YOUNG ADULT; CANCER GRADING; CANCER STAGING; CELL TRANSFORMATION; DNA METHYLATION; GENETICS; NEOPLASM; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; FEMALE; GENES, APC; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84879252959     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0106-4     Document Type: Article

References (35)

1. D.M. Parkin, F. Bray, J. Ferlay et al., Global cancer statistics, 1998. CA Cancer J. Clin. 55, 74-108 (2005)
2. A. Nandakumar, Biennial Report (1990-96) of National Cancer Registry Programme, Indian Council of Medical Research (National Printing Press, New Delhi, 2001)
3. C.C. Boring, T.S. Squires, T. Tong, S. Montgomery, Cancer statistics, 1994. CA Cancer J. Clin. 44, 7-26 (1994)
4. S.H. Wei, C. Balch, H.H. Paik, Y.S. Kim, R.L. Baldwin, S. Liyanarachchi et al., Prognostic DNA methylation biomarkers in ovarian cancer. Clin. Cancer Res. 12, 2788-2794 (2006)
5. P.A. Jones, S.B. Baylin, The epigenomics of cancer. Cell 128, 683-692 (2007)
6. P.M. Warnecke, T.H. Bestor, Cytosine methylation and human cancer. Curr. Opin. Oncol. 12, 68-73 (2000)
7. S.B. Baylin, J.G. Herman, DNA Hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 16, 168-174 (2000)
8. P.B. Makarla, M.H. Saboorian, R. Ashfaq, K.O. Toyooka, S. Toyooka, J.D. Minna et al., Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin. Cancer Res. 11, 5365-5369 (2005)
9. I. Ibanez de Caceres, C. Battagli, M. Esteller, J.G. Herman, E. Dulaimi, M.I. Edelson et al., Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res. 64, 6476-6481 (2004)
10. J.H. Yoon, R. Dammann, G.P. Pfeifer, Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Int. J. Cancer 94, 212-217 (2001)
11. A. Rathi, A.K. Virmani, J.O. Schorge, K.J. Elias, R. Maruyama, J.D. Minna et al., Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin. Cancer Res. 8, 3324-3331 (2002)
12. A. Agathanggelou, S. Honorio, D.P. Macartney, A. Martinez, A. Dallol, J. Rader et al., Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20, 1509-1518 (2001)
13. M. Yanokura, K. Banno, M. Kawaguchi, N. Hirao, A. Hirasawa, N. Susumu et al., Relationship of aberrant DNA Hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer. Oncol Rep. 17, 41-48 (2007)
14. M. Wallner, A. Herbst, A. Behrens, A. Crispin, P. Stieber, B. Goke et al., Methylation ofserum DNA is an independent prognostic marker in colorectal cancer. Clin. Cancer Res. 12, 7347-7352 (2006)
15. A. Agathanggelou, W.N. Cooper, F. Latif, Role of the Rasassociation domain family1 tumor suppressor gene in human cancers. Cancer Res. 65, 3497-3508 (2005)
16. G.P. Pfeifer, R. Dammann, Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) 70, 576-583 (2005)
17. L. Liu, R.R. Broaddus, J.C. Yao et al., Epigenetic alterations in neuroendocrine tumors: Methylation of RASassociation domain family1, isoform A and p16 genes are associated with metastasis. Mod. Pathol. 18, 1632-1640 (2005)
18. D.G. Burbee, E. Forgacs, M.S. Zochbauer et al., Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst. 93, 691-699 (2001)
19. R. Dammann, C. Li, J.H. Yoon, P.L. Chin, S. Bates, G.P. Pfeifer, Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25, 315-319 (2000)
20. K. Dreijerink, E. Braga, I. Kuzmin et al., The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98, 7504-7509 (2001)
21. Y.L. Choi, S.Y. Kang, Y.K. Shin, J.S. Choi, S.H. Kim, S.J. Lee et al., Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas. Virchows Arch. 448, 331-336 (2006)
22. M. Cul'bova, Z. Lasabova, A. Stanclova, P. Tilandyova, P. Zubor, R. Fiolka et al., Methylation of selected tumor-supressor genes in benign and malignant ovarian tumors. Ceska Gynekol 76(4), 274-279 (2011)
23. S. Kassler, H. Donninger, M.J. Birrer, G.J. Clark, RASSF1A and the taxol response in ovarian cancer. Mol. Biol. Int (2012). doi:10.1155/2012/263267
24. P.J. Morin, B. Vogelstein, K.W. Kinzler, Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93, 7950-7954 (1996)
25. G.H. Baeg, A. Matsumine, T. Kuroda et al., The tumor suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J. 14, 5618-5625 (1995)
26. M. Ilyas, J. Staub, I.P. Tomlinson, W.F. Bodmer, Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35, 1986-2002 (1999)
27. S.M. Powell, N. Zilz, Y. Beazer-Barclay et al., APC mutations occur early during colorectal tumorigenesis. Nature (Lond.) 359, 235-237 (1992)
28. S. Honorio, A. Agathanggelou, M. Schuermann, W. Pankow, P. Viacava, E.R. Maher et al., Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Oncogene 22, 147-150 (2003)
29. I.H. Wong, J. Chan, J. Wong, P.K. Tam, Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia. Clin. Cancer Res. 10, 994-1002 (2004)
30. M.C.Y. Xing, E. Mambo, G. Tallini, R. Udelsman, P.W. Ladenson, D. Sidransky, Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res. 64, 1664-1668 (2004)
31. S. Eissa, M. Swella, I.M. El-Khouly, S.K. Kassim, H. Shehata, A. Mansour et al., Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Cancer Epidemiol Biomarkers Prev. 20(8), 1657-1664 (2011)
32. H.Y. Yoon, S.K. Kim, Y.W. Kim, H.W. Kang, S.C. Lee, K.H. Ryu et al., Combined hypermethylation of APC andGSTP1 as a molecular marker for prostate cancer: Quantitative pyrosequencing analysis. J. Biomol. Screen. (2012). doi:10.1177/1087057112444445
33. S.E. Russell, W.G. McCluggage, A multistep model for ovarian tumorigenesis: The value of mutation analysis in the KRAS and BRAF genes. J. Pathol. 203, 617-619 (2004)
34. C.J. Link Jr., E. Reed, G. Sarosy, E.C. Kohn, Borderline ovarian tumors. Am. J. Med. 101, 217-225 (1996)
35. R.E. Scully, Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Bull Cancer. 69, 228-238 (1982)